These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 1313161

  • 1. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB, Soffietti R, Riva A, Stura G, Sales S, Schiffer D.
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [Abstract] [Full Text] [Related]

  • 2. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
    Kapp JP, Vance R.
    J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
    [No Abstract] [Full Text] [Related]

  • 3. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR, Pu PY, Mohamed AN, Galicich JH, Ebrahim SA, Shapiro WR.
    Cancer; 1993 Jun 15; 71(12):4007-21. PubMed ID: 8389658
    [Abstract] [Full Text] [Related]

  • 4. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
    Papavero L, Loew F, Jaksche H.
    Acta Neurochir (Wien); 1987 Jun 15; 85(3-4):128-37. PubMed ID: 3035882
    [Abstract] [Full Text] [Related]

  • 5. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW, Parkinson D, Wolpert SM, Kasdon DL, Kwan ES, Laucella M, Anderson ML.
    Neurosurgery; 1987 Apr 15; 20(4):577-83. PubMed ID: 3587550
    [Abstract] [Full Text] [Related]

  • 6. Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
    Greenberg HS, Ensminger WD, Layton PB, Gebarski S, Meyer M, Chaffee B, Bender JF, Grillo-Lopez AJ.
    Cancer Treat Rep; 1986 Mar 15; 70(3):353-7. PubMed ID: 3006913
    [Abstract] [Full Text] [Related]

  • 7. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L, Vitanovics D, Afra D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):394-9. PubMed ID: 15662767
    [Abstract] [Full Text] [Related]

  • 8. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D, Sipos L, Afra D.
    Neoplasma; 2002 Nov 20; 49(5):342-5. PubMed ID: 12458335
    [Abstract] [Full Text] [Related]

  • 9. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl)-1-nitrosourea and alpha-difluoromethylornithine.
    Prados M, Rodriguez L, Chamberlain M, Silver P, Levin V.
    Neurosurgery; 1989 Jun 20; 24(6):806-9. PubMed ID: 2546093
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 20; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 15. Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.
    Clayman DA, Wolpert SM, Heros DO.
    AJNR Am J Neuroradiol; 1989 Aug 20; 10(4):767-71. PubMed ID: 2549772
    [Abstract] [Full Text] [Related]

  • 16. Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.
    Raizer JJ, Malkin MG, Kleber M, Abrey LE.
    Neuro Oncol; 2004 Jul 20; 6(3):247-52. PubMed ID: 15279717
    [Abstract] [Full Text] [Related]

  • 17. Intra-arterial BCNU in the treatment of recurrent medulloblastoma.
    Watne K, Hager B, Hirschberg H.
    J Neurooncol; 1990 Apr 20; 8(2):139-43. PubMed ID: 2358848
    [Abstract] [Full Text] [Related]

  • 18. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study.
    West CR, Avellanosa AM, Barua NR, Patel A, Hong CI.
    Neurosurgery; 1983 Oct 20; 13(4):420-6. PubMed ID: 6314173
    [Abstract] [Full Text] [Related]

  • 19. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
    Hochberg FH, Pruitt AA, Beck DO, DeBrun G, Davis K.
    J Neurosurg; 1985 Dec 20; 63(6):876-80. PubMed ID: 2997415
    [Abstract] [Full Text] [Related]

  • 20. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA, Crafts DC, Wilson CB, Schultz MJ, Boldrey EB, Enot KJ, Pischer TL, Seager M, Elashoff RM.
    Cancer Treat Rep; 1976 Mar 20; 60(3):243-9. PubMed ID: 177210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.